Genio is a different approach to hypoglossal nerve stimulation (HGNS) for the treatment of OSA. Genio’s unique design ...

CLEARWATER, Fla., June 24, 2025 /PRNewswire/ -- Genio, a provider of learning tools that significantly improve student success, today released the Genio New Majority Learner Report 2025.

After years of being cleared on the European market, Nyxoah’s neuromodulation therapy for obstructive sleep apnea has now ...

“AI can be used as a gym – a place for training, challenge, and growth – or as a diet pill, a way to bypass effort in the ...

Nyxoah NYXH recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apnea (OSA). Featuring a leadless, battery-free design powered by an ...

Genio also unveiled The Confident Notetaker's Masterclass, an hour-long, tool-agnostic interactive course created by learning experts that teaches participants techniques and strategies to enhance ...

The FDA has approved the Genio® system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an ...